DailyDoctor Archive Specialties Get app
Back to the 12 October 2026 edition

Practice changer · 07 of 07

External oblique intercostal block roughly halved early opioid use after laparoscopic cholecystectomy

Consider asking your anaesthesia team whether a fascial plane block fits your enhanced recovery pathway for laparoscopic cholecystectomy, noting the evidence is a small single-centre trial.

Design
Single-centre, prospective, randomised parallel-group trial
Population
56 adults having elective laparoscopic cholecystectomy
Primary outcome
Total butorphanol consumption in the first 24 hours
Effect
46.5% lower consumption (95% CI 38.3 to 53.6); median 3.7 mg versus 7.2 mg

In a single-centre trial, 56 patients having elective laparoscopic cholecystectomy were randomised to a bilateral ultrasound-guided external oblique intercostal plane block or no block. All received standard anaesthesia and butorphanol patient-controlled analgesia.

Median 24-hour butorphanol use was 3.7 mg with the block versus 7.2 mg without, and after adjustment consumption was 46.5% lower (95% CI 38.3 to 53.6). The block group had higher recovery scores at 24 hours (median 140 versus 131), earlier first flatus (18 versus 20 hours) and lower cough-pain scores. Intraoperative haemodynamics did not differ.

The trial is small, from one centre, with no blinding described in the abstract, and the primary outcome was opioid consumption rather than pain or safety. It supports trying the block within an enhanced recovery pathway, with the anaesthesia team's skill and local resources deciding feasibility.

  • Block cut 24-hour butorphanol use by 46.5% after adjustment.
  • Quality of recovery score was higher at 24 hours.
  • First flatus came about two hours sooner.
  • Only 56 patients at one centre.
  • Raise regional options with your anaesthesia team for elective laparoscopic cholecystectomy.

Why it matters

It points to a regional technique that spares opioids without longer operating time or haemodynamic cost.

Don't overread it

This was a single-centre trial of 56 patients with opioid use as the main outcome, so it cannot establish safety or long-term benefit.

The statistics, in plain English

A 46.5% reduction with an interval of 38.3% to 53.6% is precise for opioid consumption in this trial, but 28 patients per arm limits what it can say about rarer complications or about other settings.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

surgcompuppergihpbmis

Tomorrow morning, before your first patient

One edition a day for general surgery, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app